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Re-evaluation of the oxidized LDL hypothesis: Prospects
for oxidized LDL found in vivo
Hiroyuki Itabe
Department of Biological Chemistry, Showa University School of Pharmacy
Abstract
The oxidized LDL hypothesis has been widely accepted as a possible explanation for the 
occurrence and development of atherosclerosis. This study demonstrates that oxidative 
modification of LDL is an important factor in cardiovascular diseases by determining small 
amounts of oxidized LDL present in human plasma. However, it has been epidemiologically 
difficult to prove any antiatherogenic effects of antioxidative vitamins. Recent research 
provides new information on this aspect, and the clinical relevance of oxidized LDL requires 
reevaluation. It is possible that oxidized LDL may be useful as biomarker of oxidative stress in 
vivo.
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